We look forward to helping you develop your compounds.
ZeClinics is an early-phase biopharma CRO using zebrafish for the discovery, safety and efficacy screenings of novel drugs. We combine our in-house technical expertise with a highly diversified portfolio to reduce by 10-fold our clients' time and cost requirements. Our services range from high-throughput screenings, cutting-edge CRISPR/cas9 gene-editing and phenotypic models.
Zebrafish is an alternative vertebrate model as a useful tool for the mechanism elucidation and drug discovery of various eye disorders, such as cataracts, glaucoma, diabetic retinopathy, age-related macular degeneration, photoreceptor degeneration, etc. The genetic and embryonic accessibility of zebrafish in combination with a behavioural assessment of visual function has made it a very popular model in ophthalmology. Zebrafish has also been widely used in ocular drug discovery, such as the screening of new anti-angiogenic compounds or neuroprotective drugs, and the ocular toxicity test.